FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2078746080> ?p ?o ?g. }

• W2078746080 endingPage "337" @default.
• W2078746080 startingPage "333" @default.
• W2078746080 abstract "The most abundant malignant brain tumor in human is glioblastoma and patients with this type of tumor have a poor prognosis with high mortality. Glioblastoma are characterized particularly by fast growth and a dependence on blood vessel formation for survival. Cannabinoids (CBs) inhibit tumor growth by inducing apoptosis of tumor cells and impairing tumor angiogenesis. The distribution of CB1 and CB2 receptors in glioblastoma and associated endothelial vessels is still unknown. Tissue samples were collected consecutively after neurosurgery of 19 patients suspected glioblastoma and examined immunohistochemically for CB1 and CB2 receptor expression. Vessel endothelial cells of the sections were immunocytochemically identified by using a primary antibody against PECAM-1. Double labelling was performed for CB receptors and endothelial cells of the vessels by DAPI staining. In endothelia of control tissue, about 24% and 45% of the cells were positive for CB1 and CB2 receptors. In glioblastoma endothelial cells, CB1 and CB2 receptors were present in about 38% and 54% of the cells respectively. In comparison to CB1, an elevated CB2 receptor expression was identified in glioblastoma. The abundant expression and distribution of CB2 receptors in glioblastoma and particularly endothelial cells of glioblastoma indicate that impaired tumor growth in presence of CB may be associated with CB2 activation. Selective CB2 agonists might become important targets attenuating vascular endothelial growth factor (VEGF) signalling and thereby diminishing neoangiogenesis and glioblastoma growth." @default.
• W2078746080 created "2016-06-24" @default.
• W2078746080 creator A5006454522 @default.
• W2078746080 creator A5008171011 @default.
• W2078746080 creator A5025738924 @default.
• W2078746080 creator A5028824639 @default.
• W2078746080 creator A5036029296 @default.
• W2078746080 creator A5036164605 @default.
• W2078746080 creator A5068601911 @default.
• W2078746080 creator A5090603265 @default.
• W2078746080 date "2009-06-01" @default.
• W2078746080 modified "2023-10-15" @default.
• W2078746080 title "Predominant CB2 receptor expression in endothelial cells of glioblastoma in humans" @default.
• W2078746080 cites W151414223 @default.
• W2078746080 cites W1964440995 @default.
• W2078746080 cites W1964570763 @default.
• W2078746080 cites W1965071866 @default.
• W2078746080 cites W1969546495 @default.
• W2078746080 cites W1978347183 @default.
• W2078746080 cites W1978764538 @default.
• W2078746080 cites W1980990150 @default.
• W2078746080 cites W1990694709 @default.
• W2078746080 cites W2013990055 @default.
• W2078746080 cites W2026018882 @default.
• W2078746080 cites W2027216690 @default.
• W2078746080 cites W2031111076 @default.
• W2078746080 cites W2033847250 @default.
• W2078746080 cites W2038470741 @default.
• W2078746080 cites W2053461680 @default.
• W2078746080 cites W2073244649 @default.
• W2078746080 cites W2082511913 @default.
• W2078746080 cites W2083438158 @default.
• W2078746080 cites W2119303378 @default.
• W2078746080 cites W2125369737 @default.
• W2078746080 cites W2149603699 @default.
• W2078746080 cites W2155473143 @default.
• W2078746080 cites W2160073127 @default.
• W2078746080 cites W2164774264 @default.
• W2078746080 cites W2793323124 @default.
• W2078746080 cites W4239769024 @default.
• W2078746080 doi "https://doi.org/10.1016/j.brainresbull.2009.01.011" @default.
• W2078746080 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19480992" @default.
• W2078746080 hasPublicationYear "2009" @default.
• W2078746080 type Work @default.
• W2078746080 sameAs 2078746080 @default.
• W2078746080 citedByCount "61" @default.
• W2078746080 countsByYear W20787460802012 @default.
• W2078746080 countsByYear W20787460802014 @default.
• W2078746080 countsByYear W20787460802015 @default.
• W2078746080 countsByYear W20787460802016 @default.
• W2078746080 countsByYear W20787460802017 @default.
• W2078746080 countsByYear W20787460802018 @default.
• W2078746080 countsByYear W20787460802019 @default.
• W2078746080 countsByYear W20787460802020 @default.
• W2078746080 countsByYear W20787460802021 @default.
• W2078746080 countsByYear W20787460802022 @default.
• W2078746080 countsByYear W20787460802023 @default.
• W2078746080 crossrefType "journal-article" @default.
• W2078746080 hasAuthorship W2078746080A5006454522 @default.
• W2078746080 hasAuthorship W2078746080A5008171011 @default.
• W2078746080 hasAuthorship W2078746080A5025738924 @default.
• W2078746080 hasAuthorship W2078746080A5028824639 @default.
• W2078746080 hasAuthorship W2078746080A5036029296 @default.
• W2078746080 hasAuthorship W2078746080A5036164605 @default.
• W2078746080 hasAuthorship W2078746080A5068601911 @default.
• W2078746080 hasAuthorship W2078746080A5090603265 @default.
• W2078746080 hasConcept C142724271 @default.
• W2078746080 hasConcept C146285616 @default.
• W2078746080 hasConcept C148001335 @default.
• W2078746080 hasConcept C150710994 @default.
• W2078746080 hasConcept C167734588 @default.
• W2078746080 hasConcept C170493617 @default.
• W2078746080 hasConcept C190283241 @default.
• W2078746080 hasConcept C2777025900 @default.
• W2078746080 hasConcept C2777527632 @default.
• W2078746080 hasConcept C2778938600 @default.
• W2078746080 hasConcept C2780394083 @default.
• W2078746080 hasConcept C502942594 @default.
• W2078746080 hasConcept C55493867 @default.
• W2078746080 hasConcept C71924100 @default.
• W2078746080 hasConcept C86803240 @default.
• W2078746080 hasConceptScore W2078746080C142724271 @default.
• W2078746080 hasConceptScore W2078746080C146285616 @default.
• W2078746080 hasConceptScore W2078746080C148001335 @default.
• W2078746080 hasConceptScore W2078746080C150710994 @default.
• W2078746080 hasConceptScore W2078746080C167734588 @default.
• W2078746080 hasConceptScore W2078746080C170493617 @default.
• W2078746080 hasConceptScore W2078746080C190283241 @default.
• W2078746080 hasConceptScore W2078746080C2777025900 @default.
• W2078746080 hasConceptScore W2078746080C2777527632 @default.
• W2078746080 hasConceptScore W2078746080C2778938600 @default.
• W2078746080 hasConceptScore W2078746080C2780394083 @default.
• W2078746080 hasConceptScore W2078746080C502942594 @default.
• W2078746080 hasConceptScore W2078746080C55493867 @default.
• W2078746080 hasConceptScore W2078746080C71924100 @default.
• W2078746080 hasConceptScore W2078746080C86803240 @default.
• W2078746080 hasIssue "5" @default.
• W2078746080 hasLocation W20787460801 @default.

• next